| Literature DB >> 35004984 |
Lu-Lu Xia1, Ting Su2, Yan Li3, Jun-Fang Mao4, Qi-Hong Zhang4, Yang-Yan Liu5.
Abstract
BACKGROUND: Percutaneous transhepatic cholangiography drainage (PTCD) effectively treats biliary obstruction. However, patients must maintain the drainage tube after hospital discharge, which may interfere with daily life and work, potentially causing psychological distress. Postoperative rehabilitation is crucial, and strengthened nursing interventions can shorten recovery time. AIM: The aim was to evaluate an inpatient model to shorten rehabilitation duration and improve quality of life after PTCD.Entities:
Keywords: Complications; Percutaneous transhepatic cholangiography drainage; Quality of life; Rapid rehabilitation model
Year: 2021 PMID: 35004984 PMCID: PMC8686152 DOI: 10.12998/wjcc.v9.i34.10530
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Demographic characteristics, n (%)
|
|
|
|
| Sex | ||
| Male | 34 (57.63) | 32 (54.24) |
| Female | 25 (42.37) | 27 (45.76) |
| Age (yr) | 62.95 ± 9.02 | 62.01 ± 9.75 |
| Obstruction site | ||
| Low | 37 (62.71) | 31 (52.54) |
| High position | 22 (37.29) | 28 (47.46) |
| Disease type | ||
| Hilar cholangiocarcinoma | 33 (55.93) | 30 (50.08) |
| Middle-lower cholangiocarcinoma | 14 (23.73) | 15 (25.42) |
| Pancreatic Head Cancer | 4 (6.78) | 8 (13.56) |
| Ampullary carcinoma | 8 (13.56) | 6 (16.95) |
| Education | ||
| Junior high school and below | 8 (13.56) | 10 (16.95) |
| Technical secondary school and high school | 19 (32.30) | 17 (28.81) |
| College degree and above | 32 (54.24) | 32 (54.24) |
| Medical insurance | ||
| Medical insurance | 31 (52.54) | 27 (45.76) |
| Business insurance | 16 (27.12) | 17 (28.81) |
| Own expense | 12 (20.34) | 15 (25.42) |
Hospitalization after percutaneous transhepatic cholangiography drainage
|
|
|
|
| Control | 15.23 ± 3.02 | 8 (13.56) |
| Observation | 13.12 ± 2.15 | 1 (1.69) |
P < 0.05 vs control group.
P < 0.05 vs control 3 mo after surgery.
Data are n (%) or mean ± SD.
Alkaline phosphatase, alanine aminotransferase, total bilirubin, and total bile acid before and after percutaneous transhepatic cholangiography drainage (mean ± SD)
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
| |
| Control | 405.63 ± 53.69 | 195.89 ± 23.16 | 121.36 ± 29.12 | 49.23 ± 6.02 | 212.03 ± 41.26 | 113.30 ± 24.03 | 115.23 ± 15.86 | 28.23 ± 8.12 |
| Observation | 412.05 ± 48.76 | 184.25 ± 18.44 | 123.63 ± 25.78 | 42.02 ± 5.69 | 204.96 ± 42.84 | 104.89 ± 16.45 | 113.86 ± 19.14 | 10.26 ± 2.47 |
P < 0.05 vs pre-intervention.
P < 0.05 vs control group.
ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; TBA: Total bile acid; TBIL: Total bilirubin.
White blood cell count and C-reactive protein before and after percutaneous transhepatic cholangiography drainage (mean ± SD)
|
|
|
| ||
|
|
|
|
| |
| Control | 14.69 ± 2.15 | 8.45 ± 1.03 | 49.63 ± 5.23 | 23.03 ± 4.11 |
| Observation | 14.71 ± 2.32 | 7.91 ± 0.89 | 50.01 ± 5.41 | 17.56 ± 2.53 |
P < 0.05 vs before percutaneous transhepatic cholangiography drainage.
P < 0.05 vs control group.
CRP: C-reactive protein; WBC: White blood cells.
Percutaneous transhepatic cholangiography drainage prolapse, n (%)
|
|
|
|
|
|
| Control | 48 (81.36) | 8 (13.56) | 3 (5.08) | 11 (18.64) |
| Observation | 57 (96.61) | 2 (3.39) | 0 (0.00) | 2 (3.39) |
P < 0.05 vs control group.
Complications after percutaneous transhepatic cholangiography drainage, n (%)
|
|
|
|
|
|
|
| Control | 3 (5.08) | 1 (1.69) | 4 (6.78) | 2 (3.39) | 10 (16.95) |
| Observation | 1 (1.69) | 0 (0.00) | 2 (3.39) | 0 (0.00) | 3 (5.08) |
P < 0.05 vs control group.
Tube-related knowledge mastery scores before and after percutaneous transhepatic cholangiography drainage (mean ± SD)
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
| |
| Control | 5.15 ± 0.54 | 7.23 ± 0.46 | 4.85 ± 0.39 | 7.14 ± 0.55 | 5.03 ± 0.41 | 7.25 ± 0.45 | 5.63 ± 0.41 | 7.74 ± 0.46 |
| Observation | 5.06 ± 0.61 | 8.72 ± 0.51 | 4.82 ± 0.45 | 8.83 ± 0.57 | 5.10 ± 0.38 | 8.57 ± 0.43 | 5.58 ± 0.46 | 9.14 ± 0.41 |
P < 0.05 vs before percutaneous transhepatic cholangiography drainage.
P < 0.05 vs control group.
PTCD: Percutaneous transhepatic cholangiography drainage.
Quality of life scores before and after percutaneous transhepatic cholangiography drainage (mean ± SD, min)
|
|
|
| ||
|
|
|
|
| |
| Fatigue | 78.23 ± 8.69 | 32.63 ± 5.36 | 77.96 ± 10.03 | 23.05 ± 4.96 |
| Pain | 66.23 ± 9.65 | 35.26 ± 4.85 | 65.96 ± 10.02 | 19.36 ± 5.02 |
| Nausea and vomiting | 68.77 ± 10.45 | 30.36 ± 4.12 | 69.02 ± 9.52 | 18.26 ± 3.69 |
| Itching | 65.32 ± 9.21 | 22.05 ± 8.14 | 64.53 ± 10.23 | 14.26 ± 4.12 |
| Emaciation | 62.55 ± 4.85 | 41.05 ± 3.86 | 62.85 ± 5.17 | 32.63 ± 4.02 |
| Fever | 58.69 ± 8.96 | 27.41 ± 6.11 | 59.04 ± 9.41 | 22.03 ± 4.01 |